A detailed history of Royal Bank Of Canada transactions in Catalent, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 721,983 shares of CTLT stock, worth $42.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
721,983
Previous 304,975 136.74%
Holding current value
$42.6 Million
Previous $17.1 Million 155.02%
% of portfolio
0.01%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.16 - $60.96 $23.4 Million - $25.4 Million
417,008 Added 136.74%
721,983 $43.7 Million
Q2 2024

Nov 06, 2024

SELL
$53.58 - $57.02 $106,195 - $113,013
-1,982 Reduced 0.65%
304,975 $17.1 Million
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $5.67 Million - $6.03 Million
105,824 Added 52.61%
306,957 $17.3 Million
Q1 2024

Nov 05, 2024

SELL
$42.56 - $59.82 $4.59 Million - $6.45 Million
-107,806 Reduced 35.12%
199,151 $11.2 Million
Q1 2024

May 15, 2024

BUY
$42.56 - $59.82 $1.33 Million - $1.87 Million
31,252 Added 18.4%
201,133 $11.4 Million
Q4 2023

Feb 14, 2024

BUY
$32.18 - $46.57 $1.1 Million - $1.59 Million
34,036 Added 25.06%
169,881 $7.63 Million
Q3 2023

Nov 14, 2023

SELL
$44.2 - $50.2 $1.16 Million - $1.32 Million
-26,317 Reduced 16.23%
135,845 $6.19 Million
Q2 2023

Aug 14, 2023

SELL
$31.86 - $67.26 $1.61 Million - $3.4 Million
-50,537 Reduced 23.76%
162,162 $7.03 Million
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $3.06 Million - $5 Million
67,341 Added 46.33%
212,699 $14 Million
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $1.06 Million - $2.08 Million
25,630 Added 21.41%
145,358 $6.54 Million
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $9.47 Million - $14.8 Million
-130,877 Reduced 52.22%
119,728 $8.66 Million
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $7.72 Million - $10.1 Million
-88,568 Reduced 26.11%
250,605 $26.9 Million
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $3.76 Million - $4.97 Million
39,921 Added 13.34%
339,173 $37.6 Million
Q4 2021

Feb 14, 2022

SELL
$119.57 - $139.07 $578,240 - $672,542
-4,836 Reduced 1.59%
299,252 $38.3 Million
Q3 2021

Nov 15, 2021

SELL
$109.17 - $142.35 $7.08 Million - $9.23 Million
-64,827 Reduced 17.57%
304,088 $40.5 Million
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $37 Million - $42.7 Million
368,915 New
368,915 $39.9 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.